Retour
Fourchette du Jour
23,28 €
24,40 €
Fourchette 52 Semaines
12,72 €
29,25 €
Volume
1 345 567
Moyenne 50J / 200J
26,10 €
/
20,79 €
Clôture Précédente
24,38 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,7 | 0,3 |
| P/B | 6,9 | 2,9 |
| ROE % | -62,5 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
35,67 €
+49.6%
Low: 16,00 €
High: 50,00 €
BPA Prévisionnel
-2,63 €
CA Est.
10 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,09 €
2,09 € – 2,09 €
|
1,3 B | 11 |
| FY2029 |
-1,37 €
-1,37 € – -1,37 €
|
460 M | 8 |
| FY2028 |
-2,46 €
-3,81 € – -1,47 €
|
110 M | 13 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -376,63M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-62,46%
ROIC-46,44%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio11,16
Interest Coverage0,00
Valorisation
P/E Ratio
-11,72
P/B Ratio6,86
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -413,84M |
| ROE | -62,46% | ROA | -53,31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -376,63M |
| ROIC | -46,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 11,16 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,72 | P/B Ratio | 6,86 |
| P/S Ratio | N/A | PEG Ratio | -0,14 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,85B | Enterprise Value | 4,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -413,84M | -259,34M | -210,96M | -156,73M | -107,43M |
| EPS (Diluted) | -2,73 | -1,88 | -1,71 | -1,43 | -1,22 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -438,15M | -270,21M | -208,28M | -156,03M | -108,12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 776,22M | 666,71M | 405,84M | 515,56M | 412,49M |
| Total Liabilities | 68,78M | 48,96M | 43,34M | 45,74M | 21,01M |
| Shareholders' Equity | 707,45M | 617,76M | 362,49M | 469,83M | 391,48M |
| Total Debt | 98 000,0 | 138 000,0 | 1,22M | 2,36M | 3,42M |
| Cash & Equivalents | 713,97M | 635,37M | 376,53M | 493,82M | 400,15M |
| Current Assets | 767,66M | 665,77M | 404,33M | 512,93M | 409,01M |
| Current Liabilities | 68,78M | 48,61M | 43,30M | 44,52M | 18,77M |